BioSpace News Archive

Biotech Bay

New Veeva Pulse Findings Show Connected Engagement Creates an Advantage as HCP Access Drops

Veeva Systems (NYSE: VEEV) today unveiled the latest findings from its Veeva Pulse Field Trends Report.

May 23, 2024
·
4 min read
CatalYm to Present Positive New Phase 2a Follow-up Data on GDF-15 Neutralizing Antibody Visugromab in Advanced NSCLC, Urothelial, and Hepatocellular Cancer at the 2024 ASCO Annual Meeting

CatalYm today announced that positive new follow-up results from its ongoing “GDFATHER” Phase 1/2a trial will be featured in an oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024 in Chicago.

May 23, 2024
·
3 min read
Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on June 6

Can-Fite BioPharma Ltd. is pleased to invite investors to a webinar on June 6, 2024, at 4:15 p.m. ET.

May 23, 2024
·
5 min read
Business

Calliditas Q1 report, January - March 2024

Operating loss amounted to SEK 203.8 million and SEK 180.1 million for the three months ended March 31, 2024, and 2023, respectively.

May 23, 2024
·
3 min read
Business

CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments

CRISPR Therapeutics, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announced the appointment of Naimish Patel, M.D., as Chief Medical Officer, effective May 28, 2024.

May 23, 2024
·
8 min read
Biotech Beach

Bionoxx to Highlight Innovative Strategy for Addressing Immune-Related Diseases at 2024 BIO International Conference

Bionoxx Inc., an innovative biotech company developing neutrophil-directed T cell modulation technology, announced it will unveil its novel immunomodulatory technology at the upcoming 2024 BIO International Convention.

May 23, 2024
·
2 min read
Business

Novo Holdings Boston office named a 2024 Best Place to Work by the Boston Business Journal

Novo Holdings, a leading life science investor, announced that its Boston office has been named a 2024 Best Place to Work by the Boston Business Journal.

May 23, 2024
·
2 min read
Business

Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance

Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the Company’s results for the quarter ended March 31, 2024.

May 23, 2024
·
23 min read
Genetown

Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference

Akebia Therapeutics today announced that John Butler, Chief Executive Officer, will present at the Jefferies Global Healthcare Conference on Wednesday, June 5 at 9:00 a.m. ET.

May 23, 2024
·
1 min read
Deals

Orna Therapeutics Announces Strategic Acquisition of ReNAgade Therapeutics to Solidify Leadership in Circular RNA Therapies

Orna Therapeutics today announced its acquisition of ReNAgade Therapeutics, a pioneer in unlocking the potential of RNA therapeutics that demonstrated industry-leading delivery to multiple extra-hepatic cells in non-human primate (NHP) models over the past 18 months.

May 23, 2024
·
4 min read